# Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma: Erratum

**Authors:** Bo Wang, Fang-Zheng Qi, Ping Chen, Luo-Meng Qian, Hui-Shan Su, Yang Wang, Chen-Hui Wang, Ya-Xin Hou, Qing Zhang, Ding Li, Zhe-Sheng Chen, Si-He Zhang

PMC · DOI: 10.7150/ijbs.128368 · International Journal of Biological Sciences · 2025-12-15

## Full-text entities

- **Genes:** PKM (pyruvate kinase M1/2) [NCBI Gene 5315] {aka CTHBP, HEL-S-30, OIP3, PK3, PKM2, TCB}
- **Diseases:** Hypoxia (MESH:D000860), hepatocellular carcinoma (MESH:D006528)
- **Chemicals:** TH-302 (MESH:C552526)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12757134/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12757134/full.md

---
Source: https://tomesphere.com/paper/PMC12757134